Biotechnology double deals...

Little old Betaville has noticed that three of the world's largest pharmaceutical giants have all recently done two major takeover deals within a few weeks, and in some cases days, of each other.

US-listed AbbVie kicked off this trend when it announced the $10 billion acquisition of Immunogen, the US-listed biopharmaceutical company, in late November. A few days later AbbVie announced the $8.7 billion takeover of Cerevel Therapeutics, another US-listed biopharmaceutical business...


Register for free to see rest of this article and all public articles from Betaville

Login / Register
Date: Wednesday, 27 December 2023, 10:54 am

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation